On September 17, uniQure announced a new plan to apply to the U.S. Food and Drug Administration (FDA) to seek approval of its gene therapy for Huntington’s disease – a dramatic shift after the agency had las...
Want to keep yourself up to date with the latest news from At Risk for Huntington's Disease?
Subscribe using the "Follow" button below and we provide you with customized updates, via topic or tag, that get delivered to your email address, your smartphone or on your dedicated news page on follow.it.
You can unsubscribe at any time painlessly.
Title of At Risk for Huntington's Disease: "At Risk for Huntington's Disease"